Cell and gene therapy trials are being delivered within a highly regulated environment, and our Cell and Gene Therapy Center of Excellence team understands what makes these trials unique and how to navigate the regulatory landscape throughout the full development lifecycle. At ProPharma Group, we share your goal to bring these life-saving treatments to patients effectively and efficiently, which is why we design these trials to help you get to the next phase quickly.
Our experts have a combined 25 years of experience delivering these novel, advanced therapeutic products to market across the EU, US, and Japan. To help you meet patient enrollment, retention, and diversity you need to successfully complete your trial, we have the in-house expertise to implement decentralized clinical trial visits that can bring treatment to patients across the globe.
Cell and Gene Therapy Expertise
We can support cell and gene therapy studies to combat many rare diseases and cancers utilizing cutting edge therapies, including but not limited to:
Cell and Gene Therapy Resources
Supporting Decentralized Gene Therapy Visits
Clinical trials often require frequent visits to the investigative site and procedures which can be a turn-off or become the reason many patients cannot commit their time to participate in a study.
Learn how ProPharma Group helped a Sponsor identify procedures and visits that could be supported offsite, which allowed patients to participate with little disruption to day-to-day life, allowing them to remain enrolled in the study.
Get Expert Guidance for Your Cell and Gene Therapy Clinical Trials
At ProPharma Group, our experts are here to help you meet your goals for cell and gene therapy trials. We understand the regulatory landscape and will partner with you to bring your products to patients around the world.
Are you looking for support for your CGT trial? Contact us to connect with a member of our team and tell us how we can help.